Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
Total Ancillary provides multiple skin substitute products in one vendor, a revolutionary software portal to manage the process, and world-class customer service. Providers using Total Ancillary for biologics (1) Have More Covered Product Options to offer their patients, (2) Treat More Patients More Confidently, and (3) Promote Superior Clinical Outcomes versus traditional wound care.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
More than 70 health-care organizations have asked the federal Drug Enforcement Administration and the Department of Health and Human Services to make permanent a waiver that allows physicians to prescribe controlled substances without an in-person visit.
Disclaimer: Stories from sources other than APMA do not necessarily reflect APMA positions or policies. APMA does not endorse these stories. This content appears in the News Brief to enhance members' understanding of how media coverage shapes perceptions of podiatric medicine, and to educate members about what their patients, legislators and other healthcare professionals are seeing in the media.
American Podiatric Medical Association, Inc.
9312 Old Georgetown Road, Bethesda, MD 20814-1621
PH: 301-581-9200 email@example.com | www.apma.org